Epidemiology, impact, and treatment options of restless legs syndrome in end-stage renal disease patients: an evidence-based review

Giannaki, Christoforos D., Hadjigeorgiou, Georgios M., Karatzaferi, Christina, Pantzaris, Marios C., Stefanidis, Ioannis and Sakkas, Giorgos K. (2013) Epidemiology, impact, and treatment options of restless legs syndrome in end-stage renal disease patients: an evidence-based review. Kidney International, 85 (6). pp. 1275-1282. ISSN 00852538

Text Epidemiology, impact, and treatment options of restless leg syndrome in end-stage renal disease patients an evidence-based review.pdf - Published Version Restricted to Repository staff only Download (448kB) | Request a copy

Abstract

Restless legs syndrome (RLS) (or Willis–Ekbom disease) is a neurological disorder with high prevalence among the end-stage renal disease population. This is one of the most predominant types of secondary RLS, and it is called uremic RLS. Despite the fact that uremic RLS has been less studied compared to idiopathic RLS, recent studies now shed light in many aspects of the syndrome including clinical characteristics, impact, epidemiology, and treatment options. The current review discusses the above topics with special emphasis given on the management of uremic RLS, including the management of symptoms that often appear during a hemodialysis session. Uremic RLS symptoms may be ameliorated by using pharmacological and nonpharmacological treatments. Evidence so far shows that both approaches may be effective in terms of reducing the RLS symptom’s severity; nevertheless, more research is needed on the efficiency of treatments for uremic RLS.

Item Type:	Article
Keywords:	Dopamine agonists, Exercise, Hemodialysis, Quality of life, Secondary RLS, Sleep disorders
Divisions:	?? UniversityCollegePlymouthMarkJohn ??
Depositing User:	Users 134 not found.
Date Deposited:	14 Feb 2017 21:23
Last Modified:	10 Aug 2020 12:40
URI:	https://marjon.repository.guildhe.ac.uk/id/eprint/15308

Actions (login required)

Edit Item